SCHEMBL1718239

SCHEMBL1718239

CC[C@H](NC(=O)c1c(CN2C(C)CCCC2C)n(-c2ccccc2)c(=O)c2ccccc12)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 12/20 0.44
TACR2 P21452 7/20 0.44
OPRM1 P35372 3/20 0.44
KCNK3 O14649 5/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
TACR1 P25103 1/20 0.42
CYP2C19 P33261 1/20 0.42
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1717944 0.89 TACR3 (0.47) TACR3TACR2OPRM1KCNK3CYP1A2
SCHEMBL1717604 0.88 TACR3 (0.44) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL1718259 0.86 TACR3 (0.43) TACR3TACR2OPRM1KCNK3CYP1A2
SCHEMBL1717437 0.86 TACR3 (0.43) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL1717716 0.85 TACR3 (0.47) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL1717937 0.85 TACR3 (0.54) TACR3TACR2OPRM1KCNK3CYP1A2
SCHEMBL1718057 0.85 TACR3 (0.56) TACR3TACR2OPRM1KCNK3CYP1A2
SCHEMBL1717752 0.84 TACR3 (0.44) TACR3TACR2OPRM1KCNK3CYP1A2
SCHEMBL1717850 0.84 TACR3 (0.44) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL1717078 0.84 TACR3 (0.46) TACR3TACR2OPRM1KCNK3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2150534-B1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS LUNDBECK & CO AS H (DK) 2012-01-11 EP claimed
EP-2150534-B1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS LUNDBECK & CO AS H (DK) 2012-01-11 EP disclosed